ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+117.2%
5Y CAGR+113.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+117.2%/yr
vs +72.3%/yr prior
5Y CAGR
+113.8%/yr
Recent acceleration
Acceleration
+44.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
44.6x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $189.02M | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $47.28M | +156.2% |
| 2022 | $18.46M | +293.8% |
| 2021 | $4.69M | +10.7% |
| 2020 | $4.23M | +316.7% |
| 2019 | $1.02M | -51.5% |
| 2018 | $2.10M | - |